Personalized acute lymphoblastic leukemia treatment let me stay true to my faith
When I was diagnosed with acute lymphoblastic leukemia — a type of blood cancer — I knew that my case was going to be a tough one. As one of Jehovah’s Witnesses, I am not willing to accept whole blood products, and acute lymphoblastic leukemia treatment sometimes includes red blood cell/platelet transfusions and/or stem cell transplants. Compromising my faith has never been an option, so one of my first concerns was finding a hospital that would respect my wishes.
Acute lymphoblastic leukemia is a fast-growing, aggressive form of cancer, so I also knew I needed to act quickly. I wanted the best and most innovative care possible, and I knew I would get that at MD Anderson. Thanks to MD Anderson’s leukemia doctors and their willingness to be creative, I’m now in remission — and the bloodless protocol they developed for me is already helping other patients.
My personalized acute lymphoblastic leukemia treatment
As I understand it, conventional acute lymphoblastic leukemia treatment works by destroying a patient’s rogue marrow and blood cells with chemotherapy — a process that ends up killing many of their healthy blood and marrow cells, too. Often, patients receive blood transfusions until their own bone marrow can replenish itself with normal cells.
But because I don’t accept blood transfusions, that plan wasn’t going to work for me. So my doctors had to formulate a new one that would kill the cancer without taking me with it. They started by prescribing IV steroids to get my white blood cell count down and red blood cell and platelet growth factors to help my body generate new blood cells more quickly.
To treat the actual cancer, they recommended five rounds of chemotherapy using a combination of vincristine, dexamethasone, and peg asparaginase, which doesn’t suppress bone marrow function, along with eight doses of a targeted therapy drug called rituximab, and eight doses of chemotherapy administered directly into my spinal fluid.
After that, they added another targeted therapy drug called blinatumomab. It was already being used to treat patients with relapsed acute lymphoblastic leukemia, but not as the initial treatment. My doctors felt I had a higher chance of staying in remission if we used it from the start, so they obtained permission from my insurance company to try it. And so far, so good.
Why my leukemia treatment continues
Leukemia is a bit of a beast, and the chances of it coming back are super high if you stop after only one cycle of chemotherapy. That’s why I’m still in treatment even after achieving remission. Once I finished all five rounds of the first four chemotherapy drugs in May 2018, I started a maintenance regimen using a different combination: mercaptopurine, methotrexate, vincristine and prednisone (sometimes called “POMP”). I’ll continue taking it until the summer of 2020.
One of the coolest things about my unique treatment is that it has already directly benefited one of my friends. He was diagnosed with the exact same type of cancer I had just a few months after I was. He, too, was interested in receiving bloodless treatment, but his doctors were very apprehensive and really didn’t know where to begin. My doctors stepped in and kindly shared their expertise with his care team. And as a result, my friend is now receiving the same treatment I am, and is also in remission. I think that really speaks to the cooperative spirit of MD Anderson.
Nothing about my treatment has been conventional. But I’ve always believed that some of life’s sourest lemons make the best lemonade. So if my experience can relieve even the tiniest bit of anxiety for other patients — and allow them to stay true to their faith as well — then I’m happy to share.